These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Liver elastography malignancy prediction score for noninvasive characterization of focal liver lesions. Grgurevic I; Bokun T; Salkic NN; Brkljacic B; Vukelić-Markovic M; Stoos-Veic T; Aralica G; Rakic M; Filipec-Kanizaj T; Berzigotti A Liver Int; 2018 Jun; 38(6):1055-1063. PubMed ID: 29028279 [TBL] [Abstract][Full Text] [Related]
4. Focal nodular hyperplasia and hepatocellular adenoma: The value of shear wave elastography for differential diagnosis. Brunel T; Guibal A; Boularan C; Ducerf C; Mabrut JY; Bancel B; Boussel L; Rode A Eur J Radiol; 2015 Nov; 84(11):2059-64. PubMed ID: 26299323 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of shearwave elastography for the characterisation of focal liver lesions on ultrasound. Guibal A; Boularan C; Bruce M; Vallin M; Pilleul F; Walter T; Scoazec JY; Boublay N; Dumortier J; Lefort T Eur Radiol; 2013 Apr; 23(4):1138-49. PubMed ID: 23160662 [TBL] [Abstract][Full Text] [Related]
6. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI. Auer TA; Walter-Rittel T; Geisel D; Schöning W; Schmelzle M; Müller T; Sinn B; Denecke T; Hamm B; Fehrenbach U BMC Med Imaging; 2021 Feb; 21(1):28. PubMed ID: 33588783 [TBL] [Abstract][Full Text] [Related]
7. Quantification of liver fat content in liver and primary liver lesions using triple-echo-gradient-echo MRI. Nougaret S; Monsonis B; Molinari N; Riviere B; Piron L; Kassam Z; Cassinotto C; Guiu B Eur Radiol; 2020 Sep; 30(9):4752-4761. PubMed ID: 32318848 [TBL] [Abstract][Full Text] [Related]
8. Can point shear wave elastography differentiate focal nodular hyperplasia from hepatocellular adenoma. Taimr P; Klompenhouwer AJ; Thomeer MGJ; Hansen BE; Ijzermans JNM; de Man RA; de Knegt RJ J Clin Ultrasound; 2018 Jul; 46(6):380-385. PubMed ID: 29740826 [TBL] [Abstract][Full Text] [Related]
9. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia. Cannella R; Rangaswamy B; Minervini MI; Borhani AA; Tsung A; Furlan A AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050 [TBL] [Abstract][Full Text] [Related]
10. Application of acoustic radiation force impulse imaging for the evaluation of focal liver lesion elasticity. Zhang P; Zhou P; Tian SM; Qian Y; Deng J; Zhang L Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):165-70. PubMed ID: 23558071 [TBL] [Abstract][Full Text] [Related]
11. Maximum Value Measured by 2-D Shear Wave Elastography Helps in Differentiating Malignancy from Benign Focal Liver Lesions. Tian WS; Lin MX; Zhou LY; Pan FS; Huang GL; Wang W; Lu MD; Xie XY Ultrasound Med Biol; 2016 Sep; 42(9):2156-66. PubMed ID: 27283039 [TBL] [Abstract][Full Text] [Related]
12. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors. Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756 [TBL] [Abstract][Full Text] [Related]
13. Utility of point shear wave elastography in characterisation of focal liver lesions. Hasab Allah M; Salama RM; Marie MS; Mandur AA; Omar H Expert Rev Gastroenterol Hepatol; 2018 Feb; 12(2):201-207. PubMed ID: 29219625 [TBL] [Abstract][Full Text] [Related]
14. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions. Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686 [TBL] [Abstract][Full Text] [Related]
15. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Grieser C; Steffen IG; Kramme IB; Bläker H; Kilic E; Perez Fernandez CM; Seehofer D; Schott E; Hamm B; Denecke T Eur Radiol; 2014 Jun; 24(6):1339-48. PubMed ID: 24658870 [TBL] [Abstract][Full Text] [Related]
16. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio. Lebert P; Adens-Fauquembergue M; Azahaf M; Gnemmi V; Behal H; Luciani A; Ernst O Eur Radiol; 2019 Nov; 29(11):5742-5751. PubMed ID: 30993437 [TBL] [Abstract][Full Text] [Related]
17. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? Roux M; Pigneur F; Baranes L; Calderaro J; Chiaradia M; Decaens T; Kastahian S; Charles-Nelson A; Tselikas L; Costentin C; Laurent A; Azoulay D; Mallat A; Rahmouni A; Luciani A Abdom Radiol (NY); 2018 Jul; 43(7):1670-1681. PubMed ID: 29110059 [TBL] [Abstract][Full Text] [Related]
18. Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence. Roche V; Pigneur F; Tselikas L; Roux M; Baranes L; Djabbari M; Costentin C; Calderaro J; Laurent A; Rahmouni A; Luciani A Eur Radiol; 2015 Jan; 25(1):186-95. PubMed ID: 25120205 [TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma. Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530 [TBL] [Abstract][Full Text] [Related]
20. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy. Bieze M; Bennink RJ; El-Massoudi Y; Phoa SS; Verheij J; Beuers U; van Gulik TM Nucl Med Commun; 2013 Feb; 34(2):146-54. PubMed ID: 23154640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]